Skip to content

Randomised trial, 2001

Does an oral contraceptive with drospirenone and ethinyl estradiol treat PMDD?

The birth control pill showed signs of helping, especially with appetite, acne, and food cravings. However, most improvements were not statistically significant, and the study had limitations.

Moderate study design 82 women with premenstrual dysphoric disorder

What they did

Double-blind placebo-controlled randomized trial where 82 women with PMDD received either oral contraceptive (3 mg drospirenone and 30 micrograms ethinyl estradiol) or placebo for three treatment cycles. Researchers measured symptoms using standard questionnaires.

What they found

The pill group showed greater improvement than placebo on nearly all 22 symptom items tested. Only one symptom group reached statistical significance: appetite, acne, and food cravings (p = 0.027). Secondary mood measures showed similar trends but were not statistically significant.

What it means for you

This pill may help PMDD symptoms, but the study showed only weak evidence. Results suggest it may work for specific symptoms like food cravings but not clearly for mood symptoms.

82

women with PMDD

3

treatment cycles

0.027

p-value for appetite, acne, food cravings

About the study

Original title
Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder
Authors
Freeman EW, Kroll R, Rapkin A et al.
Journal
Journal of women's health & gender-based medicine
Year
2001
Study design
Randomised trial
Participants
82
What was tested
Oral contraceptive containing 3 mg drospirenone and 30 micrograms ethinyl estradiol

Topics